IL31 and breast carcinoma: Since PyMT tumors that overexpress IL-31 exhibit an increase in IL-2 concentrations (figure 2E), we investigated whether there is a correlation between its expression and IL-31 or IL-31Ra in breast carcinoma biopsies from patients.